Mylan’s CEO Stands to Make Even More Off EpiPen Pricing

While Mylan’s CEO, Heather Bresch, lives in her “capitalist nirvana”- doing good for others, while doing well for herself, customers dependent on the company’s life saving medication, EpiPen, are finding it harder and harder to afford. Not only is Bresch doing well for herself, but she’s personally raking in millions of dollars every year in pay. Find out how the company’s recent proxy filings show their could be even more money going to Bresch and other top Mylan executives, here. (Source: Gretchen Morgenson, The New York Times, 9/1/16)